the aid library

LIST OPTIONS

Filter

11234

A Matter of Life and Death: Tackling Violence against Health Care in Pakistan, Peru and El Salvador

International Committee of the Red Cross (ICRC) (2017) C1

Every day, health-care providers are being attacked, patients discriminated against, ambulances held up at checkpoints, hospitals bombed, medical supplies looted and entire communities cut off from critical services around the world.
Between January 2012 and December 2014, the ICRC documented n... more

Download (492)

View PDF (637)

Hypertension Control Change Package

Centers for Disease Control and Prevention (CDC) (2020) C_CDC

second edition Included more self-measured blood pressure (SMBP)-focused content with tools and resources. Showcased more tools to find patients with potentially undiagnosed HTN. Added new strategies that focus on chronic kidney disease testing and identification.

Download (335)

View PDF (339)

ESCMID generic competencies in antimicrobial prescribing and stewardship: towards a European consensus

Dyar O.J., B. Beovic, C. Pulcini et al. Elsevier (2018) C2

Using antimicrobials responsibly is an essential component ofefforts to contain antimicrobial resistance (AMR), and to ensurethat patients receive appropriate treatment. The WHO global action plan on AMR emphasizes the importance of training healthcare professionals in antimicrobial prescribing and ... more

Download (510)

View PDF (636)

Psychosocial counselling and treatment adherence support for people affected by tuberculosis

The Union (2021) C1

The guide is suitable and can be used for the following audiences: 1. nurses and other trained healthcare workers who can use this manual as a self-study tool and then incorporate its guidance into their practice; 2. governmental and non-governmental employers of lay and professional TB treatment ... more

Download (632)

View PDF (970)

National Guidelines and Operational Manual for Programmatic Management of Drug Resistant TB (PMDT), 2nd ed.

Government of the People’s Republic of Bangladesh, Directorate General of Health Services (2013) C1

Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of Drug Resistant TB" (PMD... more

External Link

Treatments and vaccines for COVID-19

European Medicines Agency EMA (2021) CC

The European Medicines Agency (EMA) is evaluating potential COVID-19 treatments and vaccines to enable promising medicines to reach patients as soon as possible. It is also interacting with medicine developers and making use of real-world data to monitor the safety and effectiveness of medicines use... more

Download (593)

View PDF (787)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (437)

View PDF (383)

A Field Guide to Antibiotic Stewardship in Outpatient Settings

Telligen, Quality Innovation Network National Coordinating Center, Centers for Medicare & Medicaid Services (CMS) (2018) C2

Antibiotic Stewardship (AS) is a coordinated program that promotes the appropriate use of antimicrobials to improve patient outcomes, reduce microbial resistance, and decrease the spread of multi-drug resistant organisms. In clinical settings, stewardship activities focus on measuring and improving ... more

Download (379)

View PDF (473)

Corticosteroids for COVID-19

World Health Organization WHO (2020) C_WHO

WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19. We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients ... more

Download (499)

View PDF (425)

Behavorial Health Departement - Primary Care Center and fireweed Treatment Guidelines for PTSD

Sorkin, J., Chaney, G., Garcia, M.,et al. (2006) C2

This treatment guideline is intended to assist clinicians in the Behavioral Health department in treatment planning and service delivery for patients with Post Traumatic Stress Disorder (PTSD). It may also assist clinicians treating patients who have some of the signs and symptoms of PTSD but who do... more

Download (388)

View PDF (426)

IPC guidelines for ambulances transferring known or suspected COVID-19 cases
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2020) C1

These guidelines outline the minimum operational guidance for infection prevention and control (IPC) in ambulances transferring suspected or confirmed COVID-19 patients. Ambulance staff should be trained in the procedures outlined here as part of their induction and prior to starting work. They are ... more

Download (285)

View PDF (788)

The public health implications of asthma

Bousquet, J.; Bousquet, P.; Godard, P.; Daures, J. (2005) CC2

Health economics is receiving more attention as decisionmakers — including purchasers, physicians and patients seek a more comprehensive understanding of the impact of adopting new health care strategies in developed and developing countries. Formal economic evaluation is playing an increasingly i... more

Download (400)

View PDF (324)

HIV Management in Russia

V. Allan Ipsos; The Global Virology Therapy Monitor Team, Ipsos Healthcare (2013) C2

Examining the infrastructure of the Russian and USA healthcare systems with respect to the management of HIV patients

Download (1250)

View PDF (1889)

Developing, Implementing, and Monitoring the Use of Standard Treatment Guidelines: A SIAPS How-To Manual

Systems for Improved Access to Pharmaceuticals and Services (SIAPS) MSH, USAID (2015) CC

STGs are designed to assist health care professionals in making decisions about appropriate, effective patient care. However, health managers often have trouble setting and meeting the high standards required of modern, developed health care systems. With stakeholders expressing concern over issues ... more

Download (358)

View PDF (441)

Making Health Care Safer – Antibiotic Rx in Hospitals: Proceed with Caution

Centers for Disease Control and Prevention CDC (2019) C_CDC

Antibiotics save lives, but poor prescribing practices are putting patients at unnecessary risk for preventable allergic reactions, super-resistant infections, and deadly diarrhea. Errors in prescribing decisions also contribute to antibiotic resistance, making these drugs less likely to work in th... more

Download (1060)

View PDF (2095)

Policy Guidelines for Collaborative TB and HIV Services for Injecting and Other Drug Users: An Integrated Approach

World Health Organization, UNAIDS, United Nations Office on Drugs and Crime (2008)

These policy guidelines provide a strategic approach and new recommendations for integrated TB and HIV services for patients suffering from substance-abuse addiction. The key recommendations fall under three main categories: joint planning, key interventions, and overcoming barriers.

Download (328)

View PDF (444)

Guidelines for the management of asthma in adults and adolescents: Position statement of the South African Thoracic Society – 2021 update

Lalloo, U.G.; Kalla, I.S.; Abdool-Gaffar, S. et al. African Journal of Thoracic and Critical Care Medicine (2021) CC

sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support ... more

Download (574)

View PDF (450)

WHO guidelines on the use of chest imaging in COVID-19
recommended

World Health Organization WHO (2022) C_WHO

Updated 2022. This guide addresses the care pathway from presentation of the patient to a health facility to patient discharge. It considers different levels of disease severity, from asymptomatic individuals to critically ill patients. Accounting for variations in the benefits and harms of chest im... more

External Link

Major trauma backpack 2021

World Health Organization WHO (2021) C_WHO

The WHO Trauma Bag 2021 is intended to provide the resources needed to care for care of acutely ill and injured patients in hospital emergency units, field hospitals or clinics providing acute care. The Trauma Bag may also be applicable in prehospital settings if care is provided by advanced practi... more

External Link

Testing Algorithm Zika Infection

Bernhard Nocht Institute for Tropical Medicine (2016) C1

When is laboratory testing for Zika Virus infection reasonable? Testing algorithm for patients with and without symptoms.

IPC guidelines for ambulances transferring known or suspected COVID-19 cases recommended

WHO guidelines on the use of chest imaging in COVID-19 recommended

IPC guidelines for ambulances transferring known or suspected COVID-19 cases
recommended

WHO guidelines on the use of chest imaging in COVID-19
recommended